By

• Philip T Cagle MD Professor of Pathology, Department of Pathology, Weill Medical College of Cornell University, New York, NY; Director, Pulmonary Pathology, Department of Pathology, The Methodist Hospital, Houston, TX
• Timothy Allen MD, JD Professor and Chairman, Department of Pathology, The University of Texas Health Science Center at Tyler, Tyler, TX

Advances in Surgical Pathology: Lung Cancer, a volume in the Advances in Surgical Pathology series, features chapters on current and impending changes in the field of lung cancer that directly affect pathologists. This includes the 2004 updates of the WHO Classification of Tumors of the Lung; the ongoing new classification of neuroendocrine carcinomas of the lung by the International Association for the Study of Lung Cancer; the ongoing revision of the pathologic and clinical staging of lung cancer by the AJCC; molecular diagnostics in the diagnosis of lung cancer; the role of the pathologist in the new molecular targeted therapies for lung cancer; and the new use of image-guided, multimodality theranostics for the diagnosis and treatment of lung cancer. Other current topics discussed include new understanding of the premalignant and preinvasive lesions and the controversies and revisions of the diagnosis of bronchioloalveolar carcinoma.

Key Features

• Highlights recent advances and emerging technologies in the pathology of lung cancer and their relationship to clinical care
• Special focus on the convergence of pathology and radiology
• Emphasizes molecular diagnostics/testing as well as targeted therapies
• Full-color illustrations and full solution site